The study maps the contact sites between gelsolin and actin, showing that the N- and C-termini of actin are involved in binding gelsolin.
Answers are grounded in this paper and cite their sources.
Preclinical binding data warrant no clinical changes; extends actin-gelsolin structural models but leaves functional roles open.
Gelsolin was cleaved by chymotrypsin or thermolysin into an N-terminal Mr 45,000 fragment (45N) and a C-terminal Mr 38,000 fragment (38C). The N-terminal half was further cleaved into two fragments with Mr 17,000 (17N) and Mr 28,000 (28N). These fragments were complexed with actin and cross-linked with 1-ethyl-3-[3-(dimethylamino)prophyl]carbodiimide (EDC) to introduce covalent bonds into their contact sites. The location of these bonds was mapped along the actin sequence by end-label fingerprinting with highly sensitive probes for the N- and C-termini of actin. The mapping studies revealed that two gelsolin N-terminal fragments (17N and 28N) were cross-linked with the actin C-terminal segment. The result indicates that the actin N- and C-terminal segments are in the binding site of gelsolin.
No takes yet. Share an insight, caveat, or question.
Sutoh et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: